 | • レポートコード：20QY06-05722 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、骨粗しょう症薬のグローバル市場について種類別（再吸収防止薬、同化薬）、用途別（女性、男性）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・骨粗しょう症薬市場の概要 ・世界の主要地域別骨粗しょう症薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の骨粗しょう症薬市場規模2015-2026：種類別（再吸収防止薬、同化薬） ・世界の骨粗しょう症薬市場規模2015-2026：用途別（女性、男性） ・骨粗しょう症薬の北米市場規模2015-2020 ・骨粗しょう症薬のヨーロッパ市場規模2015-2020 ・骨粗しょう症薬の中国市場規模2015-2020 ・骨粗しょう症薬の日本市場規模2015-2020 ・骨粗しょう症薬の東南アジア市場規模2015-2020 ・骨粗しょう症薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Eli Lilly、Novartis、Pfizer、Amgen、Merck、Novo nordisk、Actavis、Roche） ・骨粗しょう症薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・骨粗しょう症薬の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Osteoporosis Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Osteoporosis Drugs market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Osteoporosis is a disease where decreased bone strength increases the risk of a broken bone. It is the most common reason for a broken bone among the elderly. Bones that commonly break include the back bones, the bones of the forearm, and the hip. Until a broken bone occurs there are typically no symptoms. Bones may weaken to such a degree that a break may occur with minor stress or spontaneously. Chronic pain and a decreased ability to carry out normal activities may occur following a broken bone.
Osteoporosis Drugs is a kind of medicine for Osteoporosis, such as Fosamax, Actonel, Boniva, Zoledronic Acid (Reclast or Zometa) and others.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Osteoporosis Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Osteoporosis Drugs industry.
Based on our recent survey, we have several different scenarios about the Osteoporosis Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Osteoporosis Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Osteoporosis Drugs market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Osteoporosis Drugs market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Osteoporosis Drugs market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Osteoporosis Drugs market. The report also includes nautical information, where it shows Osteoporosis Drugs market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Osteoporosis Drugs market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Osteoporosis Drugs market.
Osteoporosis, which literally means porous bone, is a disease in which the density and quality of bone are reduced. As bones become more porous and fragile, the risk of fracture is greatly increased. The loss of bone occurs silently and progressively. Often there are no symptoms until the first fracture occurs. Osteoporosis drugs are a kind of medicine for Osteoporosis. The types of osteoporosis drugs mainly include antiresorptive drugs and anabolic drugs.
The Brazil osteoporosis drugs is Very concentrated, the sales of top eight manufacturers account exceeds 70% of Brazil sales.
The antiresorptive drugs is the main types of osteoporosis drugs. In 2015, the sales revenue of antiresorptive drugs is about 109 M USD; its proportion of total osteoporosis drugs exceeds 73%.
Geographical Analysis:
Based on region, the global Osteoporosis Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Osteoporosis Drugs market are
Eli Lilly
Novartis
Pfizer
Amgen
Merck
Novo nordisk
Actavis
Roche
Segment by Type
Antiresorptive Drugs
Anabolic Drugs
Segment by Application
Female
Male
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Osteoporosis Drugs market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Osteoporosis Drugs market.
• The market share of the global Osteoporosis Drugs market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Osteoporosis Drugs market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Osteoporosis Drugs market.
1 Osteoporosis Drugs Market Overview
1.1 Osteoporosis Drugs Product Scope
1.2 Osteoporosis Drugs Segment by Type
1.2.1 Global Osteoporosis Drugs Sales by Type (2020-2026)
1.2.2 Antiresorptive Drugs
1.2.3 Anabolic Drugs
1.3 Osteoporosis Drugs Segment by Application
1.3.1 Global Osteoporosis Drugs Sales Comparison by Application (2020-2026)
1.3.2 Female
1.3.3 Male
1.4 Osteoporosis Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Osteoporosis Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Osteoporosis Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Osteoporosis Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Osteoporosis Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Osteoporosis Drugs Industry
1.5.1.1 Osteoporosis Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Osteoporosis Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Osteoporosis Drugs Players to Combat Covid-19 Impact
2 Osteoporosis Drugs Estimate and Forecast by Region
2.1 Global Osteoporosis Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Osteoporosis Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Osteoporosis Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Osteoporosis Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Osteoporosis Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Osteoporosis Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Osteoporosis Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Osteoporosis Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Osteoporosis Drugs Estimates and Projections (2015-2026)
2.4.3 China Osteoporosis Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Osteoporosis Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Osteoporosis Drugs Estimates and Projections (2015-2026)
2.4.6 India Osteoporosis Drugs Estimates and Projections (2015-2026)
3 Global Osteoporosis Drugs Competition Landscape by Players
3.1 Global Top Osteoporosis Drugs Players by Sales (2015-2020)
3.2 Global Top Osteoporosis Drugs Players by Revenue (2015-2020)
3.3 Global Osteoporosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoporosis Drugs as of 2019)
3.4 Global Osteoporosis Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Osteoporosis Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Osteoporosis Drugs Players (Opinion Leaders)
4 Global Osteoporosis Drugs Market Size by Type
4.1 Global Osteoporosis Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Osteoporosis Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Osteoporosis Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Osteoporosis Drugs Price by Type (2014-2020)
4.2 Global Osteoporosis Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Osteoporosis Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Osteoporosis Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Osteoporosis Drugs Price Forecast by Type (2021-2026)
5 Global Osteoporosis Drugs Market Size by Application
5.1 Global Osteoporosis Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Osteoporosis Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Osteoporosis Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Osteoporosis Drugs Price by Application (2015-2020)
5.2 Global Osteoporosis Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Osteoporosis Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Osteoporosis Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Osteoporosis Drugs Price Forecast by Application (2021-2026)
3 North America Osteoporosis Drugs Market Facts & Figures
3.2 North America Osteoporosis Drugs Sales Market Share by Company (2015-2020)
3.3 North America Osteoporosis Drugs Sales Market Share by Type (2015-2020)
3.4 North America Osteoporosis Drugs Sales Market Share by Application (2015-2020)
4 Europe Osteoporosis Drugs Market Facts & Figures
4.2 Europe Osteoporosis Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Osteoporosis Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Osteoporosis Drugs Sales Market Share by Application (2015-2020)
5 China Osteoporosis Drugs Market Facts & Figures
5.2 China Osteoporosis Drugs Sales Market Share by Company (2015-2020)
5.3 China Osteoporosis Drugs Sales Market Share by Type (2015-2020)
5.4 China Osteoporosis Drugs Sales Market Share by Application (2015-2020)
6 Japan Osteoporosis Drugs Market Facts & Figures
6.2 Japan Osteoporosis Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Osteoporosis Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Osteoporosis Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Osteoporosis Drugs Market Facts & Figures
7.2 Southeast Asia Osteoporosis Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Osteoporosis Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Osteoporosis Drugs Sales Market Share by Application (2015-2020)
8 India Osteoporosis Drugs Market Facts & Figures
8.2 India Osteoporosis Drugs Sales Market Share by Company (2015-2020)
8.3 India Osteoporosis Drugs Sales Market Share by Type (2015-2020)
8.4 India Osteoporosis Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Osteoporosis Drugs Business
12.1 Eli Lilly
12.1.1 Eli Lilly Osteoporosis Drugs Corporation Information
12.1.2 Eli Lilly Osteoporosis Drugs Business Overview and Total Revenue
12.1.3 Eli Lilly Osteoporosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Eli Lilly Osteoporosis Drugs Products Offered
12.1.5 Eli Lilly Recent Development
12.2 Novartis
12.2.1 Novartis Osteoporosis Drugs Corporation Information
12.2.2 Novartis Osteoporosis Drugs Business Overview and Total Revenue
12.2.3 Novartis Osteoporosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis Osteoporosis Drugs Products Offered
12.2.5 Novartis Recent Development
12.3 Pfizer
12.3.1 Pfizer Osteoporosis Drugs Corporation Information
12.3.2 Pfizer Osteoporosis Drugs Business Overview and Total Revenue
12.3.3 Pfizer Osteoporosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Osteoporosis Drugs Products Offered
12.3.5 Pfizer Recent Development
12.4 Amgen
12.4.1 Amgen Osteoporosis Drugs Corporation Information
12.4.2 Amgen Osteoporosis Drugs Business Overview and Total Revenue
12.4.3 Amgen Osteoporosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Amgen Osteoporosis Drugs Products Offered
12.4.5 Amgen Recent Development
12.5 Merck
12.5.1 Merck Osteoporosis Drugs Corporation Information
12.5.2 Merck Osteoporosis Drugs Business Overview and Total Revenue
12.5.3 Merck Osteoporosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Merck Osteoporosis Drugs Products Offered
12.5.5 Merck Recent Development
12.6 Novo nordisk
12.6.1 Novo nordisk Osteoporosis Drugs Corporation Information
12.6.2 Novo nordisk Osteoporosis Drugs Business Overview and Total Revenue
12.6.3 Novo nordisk Osteoporosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Novo nordisk Osteoporosis Drugs Products Offered
12.6.5 Novo nordisk Recent Development
12.7 Actavis
12.7.1 Actavis Osteoporosis Drugs Corporation Information
12.7.2 Actavis Osteoporosis Drugs Business Overview and Total Revenue
12.7.3 Actavis Osteoporosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Actavis Osteoporosis Drugs Products Offered
12.7.5 Actavis Recent Development
12.8 Roche
12.8.1 Roche Osteoporosis Drugs Corporation Information
12.8.2 Roche Osteoporosis Drugs Business Overview and Total Revenue
12.8.3 Roche Osteoporosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Roche Osteoporosis Drugs Products Offered
12.8.5 Roche Recent Development
13 Osteoporosis Drugs Manufacturing Cost Analysis
13.1 Osteoporosis Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Osteoporosis Drugs
13.4 Osteoporosis Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Osteoporosis Drugs Distributors List
14.3 Osteoporosis Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Osteoporosis Drugs Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Osteoporosis Drugs Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Osteoporosis Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Osteoporosis Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Osteoporosis Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Osteoporosis Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Osteoporosis Drugs Sales (K Units) by Region (2015-2020)
Table 10. Global Osteoporosis Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Osteoporosis Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Osteoporosis Drugs Revenue Share by Region (2015-2020)
Table 13. Global Osteoporosis Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Osteoporosis Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Osteoporosis Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Osteoporosis Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Osteoporosis Drugs (K Units) of Key Companies (2015-2020)
Table 18. Global Osteoporosis Drugs Sales Share by Company (2015-2020)
Table 19. Global Osteoporosis Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Osteoporosis Drugs Revenue Share by Company (2015-2020)
Table 21. Global Osteoporosis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoporosis Drugs as of 2019)
Table 22. Global Osteoporosis Drugs Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Osteoporosis Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Osteoporosis Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Osteoporosis Drugs Players
Table 27. Global Osteoporosis Drugs Sales (K Units) by Type (2015-2020)
Table 28. Global Osteoporosis Drugs Sales Share by Type (2015-2020)
Table 29. Global Osteoporosis Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Osteoporosis Drugs Price (K Units) by Type (2015-2020)
Table 31. Global Osteoporosis Drugs Sales Share by Type (2021-2026)
Table 32. Global Osteoporosis Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Osteoporosis Drugs Revenue Share by Type (2021-2026)
Table 34. Global Osteoporosis Drugs Price (K Units) by Type (2021-2026)
Table 35. Global Osteoporosis Drugs Sales (K Units) by Application (2015-2020)
Table 36. Global Osteoporosis Drugs Sales Share by Application (2015-2020)
Table 37. Global Osteoporosis Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Osteoporosis Drugs Price (K Units) by Application (2015-2020)
Table 39. Global Osteoporosis Drugs Sales (K Units) by Application (2021-2026)
Table 40. Global Osteoporosis Drugs Sales Share by Application (2021-2026)
Table 41. Global Osteoporosis Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Osteoporosis Drugs Revenue Share by Application (2021-2026)
Table 43. Global Osteoporosis Drugs Price (K Units) by Application (2021-2026)
Table 44. United States Osteoporosis Drugs Sales (K Units) by Company (2015-2020)
Table 45. United States Osteoporosis Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Osteoporosis Drugs Sales (K Units) by Type (2015-2020)
Table 47. United States Osteoporosis Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Osteoporosis Drugs Sales (K Units) by Application (2015-2020)
Table 49. United States Osteoporosis Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Osteoporosis Drugs Sales (K Units) by Company (2015-2020)
Table 51. Europe Osteoporosis Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Osteoporosis Drugs Sales (K Units) by Type (2015-2020)
Table 53. Europe Osteoporosis Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Osteoporosis Drugs Sales (K Units) by Application (2015-2020)
Table 55. Europe Osteoporosis Drugs Sales Market Share by Type (2015-2020)
Table 56. China Osteoporosis Drugs Sales (K Units) by Company (2015-2020)
Table 57. China Osteoporosis Drugs Sales Market Share by Company (2015-2020)
Table 58. China Osteoporosis Drugs Sales (K Units) by Type (2015-2020)
Table 59. China Osteoporosis Drugs Sales Market Share by Type (2015-2020)
Table 60. China Osteoporosis Drugs Sales (K Units) by Application (2015-2020)
Table 61. China Osteoporosis Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Osteoporosis Drugs Sales (K Units) by Company (2015-2020)
Table 63. Japan Osteoporosis Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Osteoporosis Drugs Sales (K Units) by Type (2015-2020)
Table 65. Japan Osteoporosis Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Osteoporosis Drugs Sales (K Units) by Application (2015-2020)
Table 67. Japan Osteoporosis Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Osteoporosis Drugs Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Osteoporosis Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Osteoporosis Drugs Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Osteoporosis Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Osteoporosis Drugs Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Osteoporosis Drugs Sales Market Share by Application (2015-2020)
Table 74. India Osteoporosis Drugs Sales (K Units) by Company (2015-2020)
Table 75. India Osteoporosis Drugs Sales Market Share by Company (2015-2020)
Table 76. India Osteoporosis Drugs Sales (K Units) by Type (2015-2020)
Table 77. India Osteoporosis Drugs Sales Market Share by Type (2015-2020)
Table 78. India Osteoporosis Drugs Sales (K Units) by Application (2015-2020)
Table 79. India Osteoporosis Drugs Sales Market Share by Application (2015-2020)
Table 80. Eli Lilly Corporation Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Osteoporosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Eli Lilly Osteoporosis Drugs Product
Table 84. Eli Lilly Recent Development
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Osteoporosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Novartis Osteoporosis Drugs Product
Table 89. Novartis Recent Development
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Osteoporosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Pfizer Osteoporosis Drugs Product
Table 94. Pfizer Recent Development
Table 95. Amgen Corporation Information
Table 96. Amgen Description and Business Overview
Table 97. Amgen Osteoporosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Amgen Osteoporosis Drugs Product
Table 99. Amgen Recent Development
Table 100. Merck Corporation Information
Table 101. Merck Description and Business Overview
Table 102. Merck Osteoporosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Merck Osteoporosis Drugs Product
Table 104. Merck Recent Development
Table 105. Novo nordisk Corporation Information
Table 106. Novo nordisk Description and Business Overview
Table 107. Novo nordisk Osteoporosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Novo nordisk Osteoporosis Drugs Product
Table 109. Novo nordisk Recent Development
Table 110. Actavis Corporation Information
Table 111. Actavis Description and Business Overview
Table 112. Actavis Osteoporosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Actavis Osteoporosis Drugs Product
Table 114. Actavis Recent Development
Table . Roche Corporation Information
Table . Roche Osteoporosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Roche Description and Business Overview
Table . Roche Osteoporosis Drugs Product
Table . Roche Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Osteoporosis Drugs Distributors List
Table 123. Osteoporosis Drugs Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Osteoporosis Drugs Product Picture
Figure 2. Global Osteoporosis Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Osteoporosis Drugs Market Share by Application in 2020 & 2026
Figure 6. Female Examples
Figure 7. Male Examples
Figure 8. Global Osteoporosis Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Osteoporosis Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Osteoporosis Drugs Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Osteoporosis Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Osteoporosis Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Osteoporosis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Osteoporosis Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Osteoporosis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Osteoporosis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Osteoporosis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Osteoporosis Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Osteoporosis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Osteoporosis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Osteoporosis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Osteoporosis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Osteoporosis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Osteoporosis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Osteoporosis Drugs Players Market Share by Revenue in Osteoporosis Drugs 2015 & 2019
Figure 26. Osteoporosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Osteoporosis Drugs Revenue Share by Type (2015-2020)
Figure 28. Global Osteoporosis Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Osteoporosis Drugs Revenue Share by Application (2015-2020)
Figure 30. Global Osteoporosis Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Osteoporosis Drugs Sales Market Share by Type in 2019
Figure 32. United States Osteoporosis Drugs Sales Market Share by Type in 2019
Figure 33. Europe Osteoporosis Drugs Sales Market Share by Company in 2019
Figure 34. Europe Osteoporosis Drugs Sales Market Share by Type in 2019
Figure 35. Europe Osteoporosis Drugs Sales Market Share by Application in 2019
Figure 36. China Osteoporosis Drugs Sales Market Share by Company in 2019
Figure 37. China Osteoporosis Drugs Sales Market Share by Type in 2019
Figure 38. China Osteoporosis Drugs Sales Market Share by Application in 2019
Figure 39. Japan Osteoporosis Drugs Sales Market Share by Company in 2019
Figure 40. Japan Osteoporosis Drugs Sales Market Share by Type in 2019
Figure 41. Japan Osteoporosis Drugs Sales Market Share by Application in 2019
Figure 42. Southeast Asia Osteoporosis Drugs Sales Market Share by Company in 2019
Figure 43. Southeast Asia Osteoporosis Drugs Sales Market Share by Type in 2019
Figure 44. Southeast Asia Osteoporosis Drugs Sales Market Share by Application in 2019
Figure 45. India Osteoporosis Drugs Sales Market Share by Company in 2019
Figure 46. India Osteoporosis Drugs Sales Market Share by Type in 2019
Figure 47. India Osteoporosis Drugs Sales Market Share by Application in 2019
Figure 48. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Novo nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Actavis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Osteoporosis Drugs
Figure 58. Manufacturing Process Analysis of Osteoporosis Drugs
Figure 59. Osteoporosis Drugs Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
エクセナチド薬の世界市場レポート2020 A recently published report by QY Research titled Global Exenatide Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate da…- リラグルチド薬の世界市場レポート2020 A recently published report by QY Research titled Global Liraglutide Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate …
- 内分泌系薬の世界市場レポート2020 Market Analysis and Insights: Global Endocrine System Drugs Market The global Endocrine System Drugs market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Endocrine System Drugs Scope and Market Size The global…
- コリン作動薬の世界市場レポート2020 Market Analysis and Insights: Global Cholinergic Drugs Market The global Cholinergic Drugs market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Cholinergic Drugs Scope and Market Size The global Cholinergic Dr…
- リンパ腫薬の世界市場レポート2020 Lymphoma is cancer that begins in infection-fighting cells of the immune system, called lymphocytes. These cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. When you have lymphoma, lymphocytes change and grow out of control. The China average price of Lymphoma D…